[Site of BCG vaccine administration and development of hypertrophic scars].
In this preliminary report, two groups of children were vaccinated with subcutaneous BCG, one on the deltoid area and the other one on the area between the spine and the scapula. The number of hypertrophic scars on the deltoid area was significantly higher that in the area between the spine and the scapula. Vaccination on this area is as effective in turning the P.P.D. positive as on the deltoid area and the risk of hypertrophic scars in minimized.
D001500:BCG Vaccine / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous / Q000009:adverse effects; D007627:Keloid / Q000209:etiology*; D008297:Male; D014376:Tuberculosis / Q000517:prevention & control
D001500:BCG Vaccine
Sitio de aplicación de la vacuna BCG y desarrollo de cicatrices hipertróficas